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TOPIC SYNOPSIS

Do Adults Utilizing Intermittent Fasting Improve Lipids
More Than Those Following a Restricted-Calorie Diet?
A Clin-IQ
Mitchell A. Sanford, DO, Tracy S. Sanford, DO, K. F. Campbell, DO, Dustin Davis, DO, Tammy
Tandberg, DO, L. N. Eagle Road, DO
Choctaw Nation Family Medicine Residency Program, Talihina, OK

Abstract	With approximately 95 million Americans diagnosed with high cholesterol, and many searching for a
nonmedicinal treatment, intermittent fasting as a method to improve health has become increasingly
popular in the lay public. We conducted a clinical inquiry to determine whether intermittent fasting
is superior to a low-calorie diet in improving lipids, searching the Cochrane, EBSCOhost, Embase,
MEDLINE, and Scopus databases using the terms intermittent fasting, lipids, and calorie-restricted
diet. Studies that included surgical weight loss or medicine-assisted weight loss were excluded. We
identified 6 published studies, 5 of which were randomized controlled trials. In reviewing the selected
studies, there did not appear to be a consistent difference in lipid change between restricted-calorie
diet and intermittent fasting. Because of differences in study methods and in how intermittent fasting
was defined, additional studies are needed. (J Patient Cent Res Rev. 2020;7:282-285.)
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Clinical Question
In adults over the age of 18, does intermittent fasting
improve lipids more than a continual restrictedcalorie diet?

in lipid levels in the intermittent fasting groups, the
difference between the methods of dietary intervention
was not statistically significant.

Brief Answer
No. Upon examining the published evidence, it became
clear that limitations of study size and/or patient
adherence, as well as between-study differences in the
specific feed/fast regulations of intermittent fasting,
cloud the comparison of results. However, if one takes
into account the differences in study methods, the
general direction of the evidence suggests that there is
not a statistically significant difference in lipid change
between intermittent fasting and continuous calorie
restriction. While some studies do show improvement

Date Answer Was Determined: November 18, 2019

Level of Evidence: A

Literature Search
Databases Searched: Cochrane databases, Embase,
EBSCOhost, MEDLINE, and Scopus.
Search Conducted: October 2019.
Inclusion Criteria: Age of 18 years or older,
randomized controlled trials, intermittent fasting diet.
Exclusion Criteria: Surgically or medically assisted
weight loss, age under 18 years.
Search Terms: Intermittent fasting, lipids, calorierestricted diet.
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Summary of Issues
It can be argued that early in human history, food
sources may not have been consistently available in all
Topic Synopsis

climates, leading to mandatory intermittent fasting in
at least a subset of populations across the planet. With
the advent of modern farming and distribution, such
deficiencies are no longer prevalent in much of the
western world, nor is mandatory intermittent fasting
a part of the typical diet seen in the United States.
Evidence is beginning to accumulate that demonstrates
that artificially reintroducing intermittent fasting can be
useful to eventuate weight loss.1 The reported efficacy
of intermittent fasting on weight loss has piqued
interest in examining what other benefits intermittent
fasting may lend. Specifically, given that 95 million
people in the United States had a total cholesterol level
above 200 mg/dl in 2014,2 the question can be raised
whether artificially reintroducing intermittent fasting
to a patient’s diet would be useful for the purpose of
reducing lipid levels.
To this end, we identified, examined, and compared 6
published articles, using the forenamed search criteria,
in an attempt to discover a consensus regarding
this issue. Five of these studies were randomized
controlled trials (RCT),1,3-6 characteristics of which
are summarized in Table 1.

Summary of Evidence
In a RCT published in 2016, Catenacci et al3 compared
zero-calorie alternate-day fasting (ADF) with daily
calorie restriction (decrease of 400 kilocalories per
day) in 25 obese adults (19 women, 6 men) over 8
weeks, with follow-up 24 weeks later. Four subjects
withdrew before completion of 8 weeks. There was
statistically significant improvement in both weight
and cholesterol in each group, but there was no
significant difference between the groups, despite
an estimated overall decrease of approximately 376
kcal consumed per day in the ADF group. Limitations
included small size, gender bias (more females than
males, making it difficult to account for body mass
index [BMI] or determine difference in applicability
between genders), and all food was provided (making
results more difficult to generalize to the greater
population).
In a RCT published in 2017, Trepanowski et al4
studied ADF versus daily calorie restriction versus
no intervention in 100 obese adults (86 women, 14
men) over 1 year consisting of 6 months of weight
loss followed by 6 months of maintenance. A total

Table 1. Study Characteristics of Individual Randomized Controlled Trials
Protocol
Catenacci et al3
IF
CER
Trepanowski et al4
IF
CER
Control

0 kcal alternating with TDEE
Decrease of 400 kcal per day

Total
cohort

8 weeks

29

12 months

100

25% CND fasting, 125% CND feast days
75% CND
No change in diet

Conley et al5
IF
CER

5:2*, 600 kcal on fasting days
Decrease of 500 kcal per day

Sundfør et al6
IF
CER

5:2*, 400 kcal women, 600 kcal men
TDEE: (400/600 kcal [female/male] x 2)/7

Pinto et al1
IF
CER

Length

6 months

6 months

4 weeks
600 kcal on 2 consecutive fasting days
Decrease of 500 kcal per day

Men

Women

3
3

10
9

4
6
4

30
29
27

23

0

28
28

26
30

6
6

15
16

Dropouts
4

31

23

1

112

45

4
3
2

*5:2 = 5 days ad libitum with 2 nonconsecutive days of fasting within a week.
CER, continuous energy restriction; CND, caloric needs daily; IF, intermittent fasting; TDEE, total daily energy expenditure.
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of 31 subjects withdrew. The ADF group consumed
25% of daily energy needs on fast days and 125% of
daily needs on “feast days” versus 75% of daily needs
every day in the restriction group. Diet logs showed
the ADF group was noncompliant, consuming excess
food on fast days and too little on “feast days.” Weight
loss was comparable between study groups. Highdensity lipoprotein (HDL) showed a statistically
significant difference at 6 months in the ADF group
compared to the daily caloric restriction group (+6.2
mg/dL), with loss of this significance by 12 months
(+1 mg/dL). Low-density lipoprotein (LDL) showed
the opposite, with lack of a statistically significant
difference at 6 months in the ADF group compared
to the daily caloric restriction group (+2.5 mg/dL),
which became statistically significant at 12 months
(+11.5 mg/dL). Limitations included noncompliance,
gender bias, and subjects limited to otherwise healthy
obese adults. After publication of this article, there
was an official comment made regarding these
limitations,7 to which Trepanowski et al concurred,
discussing that there may be benefit in a generalized
patient population but that more research would be
required to clarify this point.8
In a randomized pilot study published in 2018, Conley
et al5 examined whether a 5:2 intermittent energy
restriction diet was more effective for weight loss
compared to continuous energy restriction in 24
subjects over 6 months. All subjects were obese
male combat veterans. One subject withdrew. The
intermittent diet allowed subjects 5 days of ad
libitum eating with 2 nonconsecutive days of 600
kcal/day; the energy restriction diet decreased the
subject’s kilocalories by 500 every day. Weight
loss occurred in both groups, without a statistically
significant difference between the two, and there
was no statistically significant change in total, LDL,
and HDL cholesterol or in triglycerides in either
group. Limitations included small sample size; short
duration; and subjects limited to obese male combat
veterans, raising the question as to how applicable
these results would be to other demographics.
In a RCT published in 2018, Sundfør et al6 studied
the effects of 5:2 intermittent fasting compared to
continuous energy restriction in a group of 112 subjects
(56 women, 56 men) over 1 year. Seven subjects
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withdrew. The first 6 months included face-to-face
dietician visits; the remainder did not. The intermittent
fasting group had 5 days of ad libitum eating with 2
nonconsecutive days of 400/600 kcal (female/male)
allotted for each day. Both groups reduced energy
intake by an average of 26%–28%. While there was
weight loss, decreased triglycerides, and increased
HDL in both groups, there was no statistically
significant difference between the groups. While the
project had a longer study period and larger group of
subjects, the authors mentioned that timing of testing
was different between groups, which may have played
a slight role in blood levels. There was a lack of
activity monitoring in this study.
In a RCT published in 2019, Pinto et al1 performed
a study specifically aimed to examine if there was
cardiometabolic benefit in intermittent fasting
compared to consistent calorie restriction over a short
period of time. The 4-week study sorted 45 subjects
into two groups. Participants in the intermittent fasting
group were instructed to eat 600 kcal/day for 2 days
followed by 5 days of a Mediterranean-style diet.
Those in the consistent calorie restriction group also
followed a Mediterranean diet but were told to eat 500
less kcal/day every day, with the goal of averaging
3500 less kcal/week. Two subjects withdrew.
The researchers found that the weight loss was
comparable between study groups and that there was
no significant difference in lipid levels. Limitations
included small sample size, short length of study, and
a possible gender bias due to having 12 male subjects
to 31 female subjects. There is also the question on
how much of the benefits seen in the study are from
the change to a Mediterranean-style diet.
In a systematic review and meta-analysis of 11
RCTs, Cioffi et al9 found “comparable” changes in
both metabolic health and weight change in obese
adults, whether the patient followed a continuous or
intermittent calorie-restricted diet.
Conclusions
While current evidence is limited by study size, patient
adherence, and differing definitions of intermittent
fasting (Table 1), the studies do not show a consistent
statistically significant difference in lipid levels when
comparing calorie-restriction methods. This lack of
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consistent difference allows clinicians to discuss with
their patients that while intermittent fasting appears to
be a reasonable option for weight loss, the change in
lipid levels compared to consistent calorie restriction
is unpredictable and that further study is needed.

Patient-Friendly Recap
• Intermittent fasting, the practice of committing
a specified number of days per week to greatly
reduced calorie consumption, has emerged as
a popular diet option for weight loss.
• The authors reviewed published studies on
intermittent fasting to determine whether
this diet was better or worse at lowering
cholesterol levels compared to other lowcalorie diets that do not employ fasting.
• Based on evidence from small studies,
they found that there was no difference in
lipid levels, in terms of both HDL and LDL
cholesterol, between those who sometimes
fasted and those restricting caloric intake in a
continuous fashion.
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